Author:
Borgå Olof,Henriksson Roger,Bjermo Helena,Lilienberg Elsa,Heldring Nina,Loman Niklas
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference23 articles.
1. Konno T, Watanabe J, Ishihara K. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers. J Biomed Mater Res Part A. 2003;65(2):209–14.
2. Safavy A. Recent developments in taxane drug delivery. Curr Drug Deliv. 2008;5(1):42–54.
3. FDA, US Label. Taxol ® (paclitaxel) injection (Patient Information Included). Bristol-Myers Squibb Company. 2011. Reference ID:2939751.
http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020262s049lbl.pdf
. Accessed 8 Oct 2018.
4. Van Tellingen O, Huizing MT, Nannan Panday VR, Schellens JHM, Nooijen WJ, Beijnen JH. Cremophor EL causes (pseudo-) non-linear pharmacokinetics of paclitaxel in patients. Br J Cancer. 1999;81(2):330–5.
5. Arbour KC, Mezquita L, Long N, et al. Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer. J Clin Oncol. 2018;36(28):2872–8.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献